Consideration of regional difference in design and analysis of multi-regional trials

Pharmaceutical Statistics

Volumn 9, Issue 3, 2010, Pages 173-178

  Hung, H M James ^a   Wang, Sue Jane ^a   O'Neill, Robert T ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Global trial; I2 statistic; Inconsistency; Probability of reversal; Random effect

Indexed keywords

CLINICAL TRIAL; DRUG INDUSTRY; GEOGRAPHIC DISTRIBUTION; QUALITY CONTROL; SHORT SURVEY; STATISTICAL ANALYSIS; STATISTICAL MODEL;

DRUG APPROVAL; FACTOR ANALYSIS, STATISTICAL; GEOGRAPHY; GUIDELINES AS TOPIC; HUMANS; INTERNATIONALITY; MULTICENTER STUDIES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SMALL-AREA ANALYSIS;

EID: 77957340034     PISSN: 15391604     EISSN: 15391612     Source Type: Journal    
DOI: 10.1002/pst.440     Document Type: Short Survey

References (13)

1. ICH International Conference on Harmonization Tripartite Guidance E5. Ethnic factor in the acceptability of foreign data. The US Federal Register 1998; 83:31790-31796.
2. Ministry of Health, Labor and Welfare of Japan. Basic Principles on Global Clinical Trials, September 28, 2007.
3. Kawai N, Chuang-Stein C, Komiyama O, Li Y. An approach to rationalize partitioning sample size into individual regions in a multiregional trial. Drug Information Journal 2007; 42:139-147.
4. Sekiguchi R, Ogawa S, Uesaka H. Sample size determination of Japanese patients for multi-regional clinical trial (MRCT) in oncology. Presentation at Joint Statistical Meetings, Salt Lake City, USA, July 29 to August 2, 2007.
5. Quan H, Zhao PL, Zhang J, Roessner M, Aizawa K. Sample size considerations for Japanese patients in a multi-regional trial based on MHLW guidance. Pharmaceutical Statistics 2009; 8:1-14. DOI: 10.1002/pst.380.
6. Wang SJ. Bridging study versus prespecified regions nested in global trials. Drug Information Journal 2009; 43:27-34.
7. Uesaka H. Sample size allocation to regions in a multiregional trial. Journal of Biopharmaceutical Statistics 2009; 19:580-594.
8. Light RJ, Pillemer DB. Summing Up: The Science of Reviewing Research. Harvard University Press: Cambridge, MA, 1984.
9. Hung HMJ, O'Neill R, Bauer P, Köhne K. The behavior of the p-value when the alternative hypothesis is true. Biometrics 1997; 53:11-22.
10. Lewis S, Clarke M. Forest plots: trying to see the wood and the trees. British Medical Journal 2001; 322:1479-1480.
11. Galbraith PF. A note on graphical presentation of estimated odds ratios from several clinical trials. Statistics in Medicine 1988; 7:889-894.
12. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. British Medical Journal 2003; 327:557-560.
13. Gail M, Simon R. Testing for qualitative interactions between treatment effects and patient subsets. Biometrics 1985; 41:361-372.